---
title: AsymBio vs Xcellon Biologics
slug_a: asymbio
slug_b: xcellon
site: cdmo
review_signal_gate: closed
canonical_path: /compare/asymbio/xcellon
---

# AsymBio vs Xcellon Biologics

Side-by-side profile data from each company listing on this directory.

## AsymBio

- Profile: [/companies/asymbio](/companies/asymbio)

AsymBio — AsymBio is a CDMO providing one-stop biopharmaceutical manufacturing solutions for conjugated drugs, antibodies, and recombinant proteins, with capabilities spanning early-stage research through commercial-scale production.

Services: 5. Modalities: 3. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- Process Development

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial

## Xcellon Biologics

- Profile: [/companies/xcellon](/companies/xcellon)

Xcellon Biologics — Maryland-based CDMO for complex biologics, including antibody-drug conjugates, bispecific antibodies, and T-cell engagers. Services span bioconjugation, bioprocess and analytical/formulation development, CGMP manufacturing, and in vivo pharmacology.

Services: 10. Modalities: 3. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Discovery Research
- Protein Engineering
- Preclinical In Vivo Studies
- Bioanalysis
- Analytical Method Development & Validation
- Biologics Development & Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- Bioconjugation Services
- Process Development
- Formulation Development

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Data not yet provided.